English
Technology & science
Limited Offer
Then 99 kr. / monthCancel anytime.
Discover how tirzepatide became the first FDA-approved drug for obstructive sleep apnea, offering hope to millions struggling with CPAP machines. Julia Cartwright investigates the science, patient experiences, and clinical implications of this breakthrough treatment that goes far beyond simple weight loss. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.
Choose your subscription
Most popular
Limited Offer
Premium
20 hours of audiobooks
Podcasts only on Podimo
No ads in Podimo shows
Cancel anytime
1 month for 9 kr.
Then 99 kr. / month
Premium Plus
Unlimited audiobooks
Podcasts only on Podimo
No ads in Podimo shows
Cancel anytime
Start 7 days free trial
Then 129 kr. / month
1 month for 9 kr. Then 99 kr. / month. Cancel anytime.